Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity

References

• Gugnani HC, Gugnani A, Malachy O. Sulconazole in the therapy of dermatomycoses in Nigeria. Mycoses. 1997;40:139–141.9375503
   PubMed Web of Science ®Google Scholar
• Hercelin B, Delaunay-Vantrou M, Alamichel F, Mazza M, Marty JP. Pharmacokinetics of cutaneous Sulconazole nitrate in the hairless rat: absorption, excretion, tissue concentrations. Eur J Drug Metab Pharmacokinet. 1993;18:149–154. doi:10.1007/BF031887898243497
   PubMedGoogle Scholar
• Zhou YS, Yao JZ, Xing ZF, Li YF. Synthesis and antifungal activity of Sulconazole and its analogues. Acad J Sec Mil Med Univ. 1991;12(2):156–159.
   Google Scholar
• Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45:89–121.11104900
   PubMed Web of Science ®Google Scholar
• Lane ME, Hadgraft J, Oliveira G, Vieira R, Mohammed D, Hirata K. Rational formulation design. Int J Cosmet Sci. 2012;34:496–501. doi:10.1111/j.1468-2494.2012.00747.x22882873
   PubMed Web of Science ®Google Scholar
• Lane ME. Skin penetration enhancers. Int J Pharm. 2013;447(1–2):12–21. doi:10.1016/j.ijpharm.2013.02.04023462366
   PubMed Web of Science ®Google Scholar
• Baspinar Y, Borchert HH. Penetration and release studies of positively and negatively charged nanoemulsions—is there a benefit of the positive charge? Int J Pharm. 2012;430:247–252. doi:10.1016/j.ijpharm.2012.03.04022486953
   PubMed Web of Science ®Google Scholar
• Rai VK, Mishra N, Yadav KS, Yadav NP. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications. J Control Release. 2018;270:203–225. doi:10.1016/j.jconrel.2017.11.04929199062
   PubMed Web of Science ®Google Scholar
• Zhang J, Bozena M-K. Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: ketoprofen, lidocaine, and caffeine. Int J Pharm. 2011;421:34–44. doi:10.1016/j.ijpharm.2011.09.01421959104
   PubMed Web of Science ®Google Scholar
• Soliman Ghareb M. Nanoparticles as safe and effective delivery systems of antifungal agents: achievements and challenges. Int J Pharm. 2017;523:15–32. doi:10.1016/j.ijpharm.2017.03.01928323096
   PubMedGoogle Scholar
• Sosa L, Beatriz C, Alvarado Helen L, Nuria B, Oscar D, Calpena Ana C. Amphotericin B releasing topical nanoemulsion for the treatment of candidiasis and aspergillosis. Nanomedicine. 2017;13:2303–2312. doi:10.1016/j.nano.2017.06.02128712917
   PubMed Web of Science ®Google Scholar
• Hussain A, Singh S, Webster TJ, Ahmad FJ. New perspectives in the topical delivery of optimized amphotericin B loaded nanoemulsions using excipients with innate anti-fungal activities: a mechanistic and histopathological investigation. Nanomedicine. 2017;13:1117–1126. doi:10.1016/j.nano.2016.12.00228007632
   PubMed Web of Science ®Google Scholar
• Narang AS, Delmarre D, Gao D. Stable drug encapsulation in micelles and microemulsions. Int J Pharm. 2007;345:9–25. doi:10.1016/j.ijpharm.2007.08.05717945446
   PubMed Web of Science ®Google Scholar
• Silva AE, Barratt G, Chéron M, Egito EST. Development of oil-in-water microemulsions for the oral delivery of amphotericin B. Int J Pharm. 2013;454:641–648. doi:10.1016/j.ijpharm.2013.05.04423726904
   PubMed Web of Science ®Google Scholar
• Manikan V, Kalil MS, Hamid AA. Response surface optimization of culture medium for enhanced docosahexaenoic acid production by a Malaysian thraustochytrid. Sci Rep. 2015;5:8611. doi:10.1038/srep0861125721623
   PubMedGoogle Scholar
• Lee A, Chaibakhsh N, Rahman MBA, Basri M, Tejo BA. Optimized enzymatic synthesis of levulinate ester in solvent-free system. Ind Crops Prod. 2010;32(3):246–251. doi:10.1016/j.indcrop.2010.04.022
   Web of Science ®Google Scholar
• Liu Y, Zhang P, Feng NP, Zhang X, Wu S, Zhao JH. Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int J Pharm. 2009;365:136–142. doi:10.1016/j.ijpharm.2008.08.00918782611
   PubMed Web of Science ®Google Scholar
• Zhuang CY, Li N, Wang M, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm. 2010;394(1–2):179–185. doi:10.1016/j.ijpharm.2010.05.00520471464
   PubMed Web of Science ®Google Scholar
• Tsai MJ, Wu PC, Huang YB, et al. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm. 2012;423:461–470. doi:10.1016/j.ijpharm.2011.12.00922193056
   PubMed Web of Science ®Google Scholar
• Zhu WW, Yu AH, Wang WH, Dong RQ, Wu J, Zhai GX. Formulation design of microemulsion for dermal delivery of penciclovir. Int J Pharm. 2008;360:184–190. doi:10.1016/j.ijpharm.2008.04.00818541394
   PubMed Web of Science ®Google Scholar
• Kreilgaard M, Pedersen EJ, Jaroszewski JW. NMR characterisation and transdermal drug delivery potential of microemulsion systems. J Control Release. 2000;69:421–433.11102682
   PubMed Web of Science ®Google Scholar
• Hua L, Weisan P, Jiayu L, Ying Z. Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery. Drug Dev Ind Pharm. 2004;30:657–666. doi:10.1081/DDC-12003918315285339
   PubMed Web of Science ®Google Scholar
• Ali MS, Alam MS, Alam N, Siddiqui MR. Preparation, characterization and stability study of dutasteride loaded nanoemulsion for treatment of benign prostatic hypertrophy. Iran J Pharm Res. 2014;13:1125–1140.25587300
   PubMed Web of Science ®Google Scholar
• Li W, Chen H, He Z, Han C, Liu S, Li Y. Influence of surfactant and oil composition on the stability and antibacterial activity of eugenol nanoemulsions. Food Sci Technol. 2015;62:39–47.
   Web of Science ®Google Scholar
• Bali V, Ali M, Ali J. Study of surfactant combinations and development of a pharmacokinetics of cutaneous Sulconazole nitrate in the hairless rat: absorption, excretion, tissue concentrations. Colloids Surf B. 2010;76:410–420. doi:10.1016/j.colsurfb.2009.11.021
   PubMed Web of Science ®Google Scholar
• Yuan Jessica S, Alice Y, Nga N, Jacquelene C, Xiao-Yan W, Acosta Edgar J. Effect of surfactant concentration on transdermal lidocaine delivery with linker microemulsions. Int J Pharm. 2010;392:274–284. doi:10.1016/j.ijpharm.2010.03.05120363304
   PubMedGoogle Scholar
• Callender SP, Mathews JA, Kobernyk K, Wettig SD. Microemulsion utility in pharmaceuticals: implications for multi-drug delivery. Int J Pharm. 2017;526:425–442. doi:10.1016/j.ijpharm.2017.05.00528495500
   PubMed Web of Science ®Google Scholar
• Griesser J, Hetényi G, Kadas H, Demarne F, Jannin V, Bernkop-Schnürch A. Self-emulsifying peptide drug delivery systems: how to make them highly mucus permeating. Int J Pharm. 2018;538:159–166. doi:10.1016/j.ijpharm.2018.01.01829339247
   PubMed Web of Science ®Google Scholar
• Mitri K, Shegokar R, Gohla S, Anselmi C, Müller RH. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Int J Pharm. 2011;414:267–275. doi:10.1016/j.ijpharm.2011.05.00821596122
   PubMed Web of Science ®Google Scholar
• Fernández CF, Clares NB, López SO, Alonso MC, Calpena Campmany AC. Evaluation of novel nystatin nanoemulsion for skin candidosis infections. Mycoses. 2013;56:70–81. doi:10.1111/j.1439-0507.2012.02202.x22574899
   PubMedGoogle Scholar
• Zhang Y, Shang ZH, Gao CH, et al. Nanoemulsion for solubilization, stabilization, and in vitro release of pterostilbene for oral delivery. AAPS PharmSciTech. 2014;15:1000–1008. doi:10.1208/s12249-014-0129-424831090
   PubMed Web of Science ®Google Scholar
• Thakkar Hetal P, Amit K, Dhande Rahul D, Patel Arpita A. Formulation and evaluation of Itraconazole nanoemulsion for enhanced oral bioavailability. J Microencapsul. 2015;32:559–569. doi:10.3109/02652048.2015.106591726333939
   PubMedGoogle Scholar
• Ofokansi KC, Kenechukwu FC, Ogwu NN. Design of novel miconazole nitrate transdermal films based on eudragit RS100 and HPMC hybrids: preparation, physical characterization, in vitroandex vivostudies. Drug Deliv. 2014;22(8):1078–1085. doi:10.3109/10717544.2013.87560424455998
   PubMedGoogle Scholar